Open Access Open Access  Restricted Access Subscription Access

Signs, Symptoms, Mechanism of Action, Adverse Effects and Contraindications of Clavulanic Acid

Muralinath E., Mr. Vonteru Munisekhar, Dr. P. Prabhavathi, K. Suparnalatha, M. Harshita, Dr. G. Rajeswari, Sravani Pragna K., Guruprasad M.

Abstract


When treating bacterial infections, especially those caused by bacteria that produce beta-lactamases, clavulanic acid is a drug that can be administered in addition to amoxicillin. It belongs to the class of drugs known as beta-lactamase inhibitors. When used in conjunction with amoxicillin to treat beta-lactamase-producing bacterial infections, clavulanic acid is a valuable agent. This activity explains its indications, action, and contraindications, as well as how the interprofessional team can use this agent to promote positive outcomes regarding the fight against infections.


Full Text:

PDF

References


Drawz SM, Bonomo RA. Three decades of beta-lactamase inhibitors. Clin Microbiol Rev. 2010 Jan;23(1):160-201. [PMC free article] [PubMed]

Karlović K, Nikolić J, Arapović J. Ceftriaxone treatment of complicated urinary tract infections as a risk factor for enterococcal re-infection and prolonged hospitalization: A 6-year retrospective study. Bosn J Basic Med Sci. 2018 Nov 07;18(4):361-366. [PMC free article] [PubMed]

Akhavan BJ, Khanna NR, Vijhani P. StatPearls [Internet]. StatPearls Publishing; Treasure Island (FL): Nov 17, 2023. Amoxicillin. [PubMed]

Evans J, Hanoodi M, Wittler M. StatPearls [Internet]. StatPearls Publishing; Treasure Island (FL): Aug 11, 2024. Amoxicillin Clavulanate. [PubMed]

Jacobs MR. Extended release amoxicillin/clavulanate: optimizing a product for respiratory infections based on pharmacodynamic principles. Expert Rev Anti Infect Ther. 2005 Jun;3(3):353-60. [PubMed]

Matho A, Mulqueen M, Tanino M, Quidort A, Cheung J, Pollard J, Rodriguez J, Swamy S, Tayler B, Garrison G, Ata A, Sorum P. High-dose versus standard-dose amoxicillin/clavulanate for clinically-diagnosed acute bacterial sinusitis: A randomized clinical trial. PLoS One. 2018;13(5):e0196734. [PMC free article] [PubMed]

Chams S, El Sayegh S, Hamdon M, Kumar S, Tegeltija V. Amoxicillin/clavulanic acid-induced pancreatitis: case report. BMC Gastroenterol. 2018 Aug 02;18(1):122. [PMC free article] [PubMed]

Iravani A, Richard GA. Treatment of urinary tract infections with a combination of amoxicillin and clavulanic acid. Antimicrob Agents Chemother. 1982 Oct;22(4):672-7. [PMC free article] [PubMed]

deLemos AS, Ghabril M, Rockey DC, Gu J, Barnhart HX, Fontana RJ, Kleiner DE, Bonkovsky HL., Drug-Induced Liver Injury Network (DILIN). Amoxicillin-Clavulanate-Induced Liver Injury. Dig Dis Sci. 2016 Aug;61(8):2406-2416. [PMC free article] [PubMed]

Crass RL, Pai MP. Pharmacokinetics and Pharmacodynamics of β-Lactamase Inhibitors. Pharmacotherapy. 2019 Feb;39(2):182-195. [PubMed]

Sembera S, Lammert C, Talwalkar JA, Sanderson SO, Poterucha JJ, Hay JE, Wiesner RH, Gores GJ, Rosen CB, Heimbach JK, Charlton MR. Frequency, clinical presentation, and outcomes of drug-induced liver injury after liver transplantation. Liver Transpl. 2012 Jul;18(7):803-10. [PMC free article] [PubMed]

Hussaini SH, Farrington EA. Idiosyncratic drug-induced liver injury: an update on the 2007 overview. Expert Opin Drug Saf. 2014 Jan;13(1):67-81. [PubMed]


Refbacks

  • There are currently no refbacks.